Matches in Wikidata for { <http://www.wikidata.org/entity/Q63595467> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q63595467 description "clinical trial" @default.
- Q63595467 description "ensayu clínicu" @default.
- Q63595467 description "klinisch onderzoek" @default.
- Q63595467 description "клінічне випробування" @default.
- Q63595467 description "կլինիկական փորձարկում" @default.
- Q63595467 name "Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma" @default.
- Q63595467 type Item @default.
- Q63595467 label "Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma" @default.
- Q63595467 prefLabel "Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma" @default.
- Q63595467 P1050 Q63595467-C895017B-AA3B-4172-AF40-1F6C4862170D @default.
- Q63595467 P1132 Q63595467-AEE7A72C-FC59-4378-B588-144F5E1BF1DF @default.
- Q63595467 P1476 Q63595467-C41F68A4-DC4E-49FE-AE88-064B9E5F5D4D @default.
- Q63595467 P17 Q63595467-7120D3EC-C7B4-4B7E-B214-0C7C207BA268 @default.
- Q63595467 P2899 Q63595467-47FFCCEF-EDC2-4959-94CC-C5709B234F32 @default.
- Q63595467 P3098 Q63595467-150CD7C1-9EA9-4422-B434-2C00792F0FB0 @default.
- Q63595467 P31 Q63595467-31790D66-A41A-4516-93FA-A7FB44DC6FF5 @default.
- Q63595467 P4844 Q63595467-1CEDD7E2-145D-4B9D-9440-1DD4A54A5C9E @default.
- Q63595467 P4844 Q63595467-32CD0E73-B15A-4A69-88B9-6742D9B046CB @default.
- Q63595467 P4844 Q63595467-7BAE542C-57B4-4421-8A1B-4E86B6E46F65 @default.
- Q63595467 P4844 Q63595467-CF84FEC6-6CB0-49F1-9A7F-616A4E75C7A1 @default.
- Q63595467 P4844 Q63595467-DA67933C-94FF-425B-BF55-215EE5D9DD59 @default.
- Q63595467 P4844 Q63595467-FF0828B4-84C4-44D0-AE5D-A519D4760E79 @default.
- Q63595467 P580 Q63595467-563A89AA-C24F-4FF3-A99C-C70D5D30D494 @default.
- Q63595467 P582 Q63595467-61562F64-0BAD-43D3-8056-8E28BE1FDB6B @default.
- Q63595467 P6099 Q63595467-9B1B9836-E32C-44A0-91D0-5A0E3CE079EA @default.
- Q63595467 P8363 Q63595467-E53EF550-C77C-431F-AD5D-7B1DAE038D4C @default.
- Q63595467 P859 Q63595467-8244367B-8657-404A-8C65-4023F65A0B60 @default.
- Q63595467 P1050 Q467635 @default.
- Q63595467 P1132 "+60" @default.
- Q63595467 P1476 "A Phase 2 Study of Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone for Relapsed and/or Refractory Myeloma" @default.
- Q63595467 P17 Q30 @default.
- Q63595467 P2899 "+18" @default.
- Q63595467 P3098 "NCT03763162" @default.
- Q63595467 P31 Q30612 @default.
- Q63595467 P4844 Q15889608 @default.
- Q63595467 P4844 Q20948663 @default.
- Q63595467 P4844 Q408524 @default.
- Q63595467 P4844 Q419319 @default.
- Q63595467 P4844 Q5222113 @default.
- Q63595467 P4844 Q620730 @default.
- Q63595467 P580 "2019-01-17T00:00:00Z" @default.
- Q63595467 P582 "2023-12-31T00:00:00Z" @default.
- Q63595467 P6099 Q42824440 @default.
- Q63595467 P8363 Q78089383 @default.
- Q63595467 P859 Q1525831 @default.